HomeQuestion

Is there benefit of cold-cap use while patient is on sacituzumab-govitecan?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In a patient with metastatic PIK3CA-mutant, HR-positive, HER2-low breast cancer who is intolerant to capivasertib, would you preferentially use another PIK3 inhibitor or switch to T-DXd?

How would you approach systemic treatment of oligometastatic recurrence following surgical removal of the single area of metastasis in a patient with ER+ (20-30%), PR-negative, HER2-negative breast cancer?

1 Answers

What are the recommended prophylactic measures for managing or mitigating diarrhea when pertuzumab is combined with trastuzumab deruxtecan, given toxicity risk with each individually?

33 Answers

What are the recommended second-line treatment options for patients with metastatic HER2+ breast cancer who have received frontline trastuzumab deruxtecan (T-DXd)?

2 Answers

For first-line metastatic strongly ER/PR+, HER2-low IDC with neuroendocrine differentiation and the patient experiencing symptomatic visceral crisis, would you choose chemotherapy over CDK4/6i plus AI?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service